Business · 1 sources covering this

Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs

Pharmaceutical stocks faced pressure after US President Trump unveiled a phased tariff plan for imported generic medicines. This plan introduces steep duties on generic drugs after a two-year tariff-free window. Indian drugmakers are reassessing supply chains and investment plans due to potential future impacts. Companies without US manufacturing presence may face significantly altered economics. The announcement shifts focus to encouraging domestic production within the United States.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Times of IndiaLean R·2h ago
Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs
Pharmaceutical stocks faced pressure after US President Trump unveiled a phased tariff plan for imported generic medicines. This plan introduces steep duties on generic drugs after a two-year tariff-free window. Indian drugmakers are reassessing supply chains and investment plans due to potential future impacts. Companies without US manufacturing presence may face significantly altered economics. The announcement shifts focus to encouraging domestic production within the United States.
Read at Times of India →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/30b9df4621fc8fd84b764b69baa649697e3d97f0"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs"></iframe>

Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs

How 1 sources are covering this

Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs

More from Business

Delhi Metro Shuts 16 Stations Until Further Notice Amid Ongoing CJP's Protest — Check Full List

Ashneer Grover Biopic: Aamir Khan Exits Over Creative Differences, Says Report

CJP protest: 'Don't waste our time,' says CJI Surya Kant on plea against police action — ‘not interested in videos’

'Host of failures and corruption': Congress steps up attack, seeks Dharmendra Pradhan's resignation

Reader

Trust & legal

Across the network